EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, buy

25.11.24 12:00 Uhr

Werte in diesem Artikel
Aktien

23,40 EUR 0,00 EUR 0,00%




Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

25.11.2024 / 12:00 CET/CEST
The issuer is solely responsible for the content of this announcement.








1. Details of the person discharging managerial responsibilities / person closely associated

a) Name




Name and legal form: FUTRUE GmbH

2. Reason for the notification

a) Position / status




Person closely associated with:
Title: Dr.
First name: Clemens
Last name(s): Fischer
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
PharmaSGP Holding SE

b) LEI
3912005CZ12PVVCIPT91 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code




Type: Share
ISIN: DE000A2P4LJ5

b) Nature of the transaction


Acquisition

c) Price(s) and volume(s)




Price(s) Volume(s)
24.05 EUR 12145250.00 EUR

d) Aggregated information




Price Aggregated volume
24.05 EUR 12145250.00 EUR

e) Date of the transaction
21/11/2024; UTC+1

f) Place of the transaction




Outside a trading venue



25.11.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
















Language: English
Company: PharmaSGP Holding SE
Lochhamer Schlag 1
82166 Gräfelfing
Germany
Internet: https://pharmasgp.com



 
End of News EQS News Service





95475  25.11.2024 CET/CEST





Ausgewählte Hebelprodukte auf PharmaSGP

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf PharmaSGP

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu PharmaSGP